Expression, purification, and analysis of three recombinant ECD disintegrins (r-colombistatins) from P-III class snake venom metalloproteinases affecting platelet aggregation and SK-MEL-28 cell adhesion
- PMID: 27641750
- PMCID: PMC5175399
- DOI: 10.1016/j.toxicon.2016.09.007
Expression, purification, and analysis of three recombinant ECD disintegrins (r-colombistatins) from P-III class snake venom metalloproteinases affecting platelet aggregation and SK-MEL-28 cell adhesion
Abstract
Crotalid venoms are rich sources of components that affect the hemostatic system. Snake venom metalloproteinases are zinc-dependent enzymes responsible for hemorrhage that also interfere with hemostasis. The disintegrin domain is a part of snake venom metalloproteinases, which involves the binding of integrin receptors. Integrins play an essential role in cancer survival and invasion, and they have been major targets for drug development and design. Both native and recombinant disintegrins have been widely investigated for their anti-cancer activities in biological systems as well as in vitro and in vivo systems. Here, three new cDNAs encoding ECD disintegrin-like domains of metalloproteinase precursor sequences obtained from a Venezuelan mapanare (Bothrops colombiensis) venom gland cDNA library have been cloned. Three different N- and C-terminal truncated ECD disintegrin-like domains of metalloproteinases named colombistatins 2, 3, and 4 were amplified by PCR, cloned into a pGEX-4T-1 vector, expressed in Escherichia coli BL21, and tested for inhibition of platelet aggregation and inhibition of adhesion of human skin melanoma (SK-Mel-28) cancer cell lines on collagen I. Purified recombinant colombistatins 2, 3, and 4 were able to inhibit ristocetin- and collagen-induced platelet aggregation. r-Colombistatins 2 showed the most potent inhibiting SK-Mel-28 cancer cells adhesion to collagen. These results suggest that colombistatins may have utility in the development of therapeutic tools in the treatment of melanoma cancers and also thrombotic diseases.
Keywords: Bothrops colombiensis; Colombistatins; ECD disintegrin-like domain; SK-Mel-28; Tumor.
Copyright © 2016. Published by Elsevier Ltd.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures




Similar articles
-
Colombistatin: a disintegrin isolated from the venom of the South American snake (Bothrops colombiensis) that effectively inhibits platelet aggregation and SK-Mel-28 cell adhesion.Arch Toxicol. 2009 Mar;83(3):271-9. doi: 10.1007/s00204-008-0358-y. Epub 2008 Oct 2. Arch Toxicol. 2009. PMID: 18830584
-
cDNA cloning of a snake venom metalloproteinase from the eastern diamondback rattlesnake (Crotalus adamanteus), and the expression of its disintegrin domain with anti-platelet effects.Toxicon. 2013 Mar 15;64:43-54. doi: 10.1016/j.toxicon.2012.12.025. Epub 2013 Jan 10. Toxicon. 2013. PMID: 23313448 Free PMC article.
-
Examination of the Efficacy and Cross-Reactivity of a Novel Polyclonal Antibody Targeting the Disintegrin Domain in SVMPs to Neutralize Snake Venom.Toxins (Basel). 2021 Mar 31;13(4):254. doi: 10.3390/toxins13040254. Toxins (Basel). 2021. PMID: 33807363 Free PMC article.
-
Snake venom metalloproteinases and disintegrins: interactions with cells.Braz J Med Biol Res. 1998 Jul;31(7):853-62. doi: 10.1590/s0100-879x1998000700001. Braz J Med Biol Res. 1998. PMID: 9698750 Review.
-
Snake venom metalloproteinase containing a disintegrin-like domain, its structure-activity relationships at interacting with integrins.Curr Med Chem Cardiovasc Hematol Agents. 2005 Jul;3(3):249-60. doi: 10.2174/1568016054368205. Curr Med Chem Cardiovasc Hematol Agents. 2005. PMID: 15974889 Review.
Cited by
-
Cell migration inhibition activity of a non-RGD disintegrin from Crotalus durissus collilineatus venom.J Venom Anim Toxins Incl Trop Dis. 2018 Oct 20;24:28. doi: 10.1186/s40409-018-0167-6. eCollection 2018. J Venom Anim Toxins Incl Trop Dis. 2018. PMID: 30377432 Free PMC article.
-
Crosstalk of Inflammation and Coagulation in Bothrops Snakebite Envenoming: Endogenous Signaling Pathways and Pathophysiology.Int J Mol Sci. 2023 Jul 15;24(14):11508. doi: 10.3390/ijms241411508. Int J Mol Sci. 2023. PMID: 37511277 Free PMC article. Review.
-
Bicistronic Vector Expression of Recombinant Jararhagin-C and Its Effects on Endothelial Cells.Toxins (Basel). 2024 Dec 3;16(12):524. doi: 10.3390/toxins16120524. Toxins (Basel). 2024. PMID: 39728782 Free PMC article.
-
Targeting Metastasis with Snake Toxins: Molecular Mechanisms.Toxins (Basel). 2017 Nov 30;9(12):390. doi: 10.3390/toxins9120390. Toxins (Basel). 2017. PMID: 29189742 Free PMC article. Review.
-
Recombinant and Chimeric Disintegrins in Preclinical Research.Toxins (Basel). 2018 Aug 7;10(8):321. doi: 10.3390/toxins10080321. Toxins (Basel). 2018. PMID: 30087285 Free PMC article. Review.
References
-
- Albelda SM, Mette SA, Elder DE, Stewart R, Damjanovich L, Herlyn M, Buck CA. Integrin distribution in malignant melanoma: association of the j93 subunit with tumor progression. Cancer Res. 1990;50:6757–6764. - PubMed
-
- . Principles of Laboratory Animal Care. National Institute of Health; USA: 1985. Pub, 85 No. 23.
-
- Bjarnason JB, Fox JW. Hemorrhagic metalloproteinases from snake venom. Pharmacol Ther. 1994;62:325–372. - PubMed
-
- Boukerche HO, Berthier-Vergnes M, Bailly JF, Dore LK, Leung JL, McGregor A monoclonal antibody (LYP18) directed against the blood platelet glycoprotein Ib/IIIa complex inhibits human melanoma growth in vivo. Blood. 1989;74:909–912. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources